Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin R Flaherty

Showing results (161-170 of 204) with videos related to

Pageof 21
Sort By:
Respiratory Research|March 14, 2020
Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trialKevin J Anstrom, Imre Noth, Kevin R Flaherty, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Computational Deconvolution of Cell Type-Specific Gene Expression in COPD and IPF Lungs Reveals Disease Severity AssociationsMin Hyung Ryu, Jeong H Yun, Kangjin Kim, et al.
Annals of the American Thoracic Society|August 11, 2020
The Pulmonary Fibrosis Foundation Patient Registry. Rationale, Design, and MethodsBonnie R Wang, Rex Edwards, Elizabeth A Freiheit, et al.
Annals of the American Thoracic Society|June 23, 2017
Usual Interstitial Pneumonia Can Be Detected in Transbronchial Biopsies Using Machine LearningDaniel G Pankratz, Yoonha Choi, Urooj Imtiaz, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2017
A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group PerspectiveChristopher J Ryerson, Tamera J Corte, Joyce S Lee, et al.
JAMA|May 11, 2021
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical TrialFernando J Martinez, Eric Yow, Kevin R Flaherty, et al.
American Journal of Respiratory and Critical Care Medicine|July 18, 2025
A Quantitative Imaging Measure of Progressive Pulmonary FibrosisJennifer M Wang, Ayodeji Adegunsoye, Janelle Vu Pugashetti, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2024
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical TrialLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
The New England Journal of Medicine|May 18, 2026
Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary FibrosisSteven D Nathan, Peter Smith, Chunqin Deng, et al.
The Lancet. Respiratory Medicine|August 14, 2018
Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trialGanesh Raghu, Carlos A Pellegrini, Eric Yow, et al.
Pageof 21

Showing results (161-170 of 204) with videos related to

Sort By:
Pageof 21
Respiratory Research|March 14, 2020
Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trialKevin J Anstrom, Imre Noth, Kevin R Flaherty, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Computational Deconvolution of Cell Type-Specific Gene Expression in COPD and IPF Lungs Reveals Disease Severity AssociationsMin Hyung Ryu, Jeong H Yun, Kangjin Kim, et al.
Annals of the American Thoracic Society|August 11, 2020
The Pulmonary Fibrosis Foundation Patient Registry. Rationale, Design, and MethodsBonnie R Wang, Rex Edwards, Elizabeth A Freiheit, et al.
Annals of the American Thoracic Society|June 23, 2017
Usual Interstitial Pneumonia Can Be Detected in Transbronchial Biopsies Using Machine LearningDaniel G Pankratz, Yoonha Choi, Urooj Imtiaz, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2017
A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group PerspectiveChristopher J Ryerson, Tamera J Corte, Joyce S Lee, et al.
JAMA|May 11, 2021
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical TrialFernando J Martinez, Eric Yow, Kevin R Flaherty, et al.
American Journal of Respiratory and Critical Care Medicine|July 18, 2025
A Quantitative Imaging Measure of Progressive Pulmonary FibrosisJennifer M Wang, Ayodeji Adegunsoye, Janelle Vu Pugashetti, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2024
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical TrialLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
The New England Journal of Medicine|May 18, 2026
Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary FibrosisSteven D Nathan, Peter Smith, Chunqin Deng, et al.
The Lancet. Respiratory Medicine|August 14, 2018
Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trialGanesh Raghu, Carlos A Pellegrini, Eric Yow, et al.
Pageof 21